Soteria Bio is an innovative formulation platform, built around patented excipients, enabling the direct and targeted delivery of biomolecules such as antibodies to the pulmonary airways. By focusing on local administration, Soteria Bio aims to significantly reduce required doses, improving the balance between efficacy and safety while lowering production costs and increasing treatment accessibility. The initial pipeline targets inhaled antibody therapies for chronic inflammatory diseases like asthma and COPD, as well as infectious respiratory diseases.
Company Details
- Address
- Montpellier
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- ABIESSENCES.
Soteria Bio Questions
Soteria Bio's LinkedIn profile is https://www.linkedin.com/company/soteriabio
Soteria Bio's industry is
Biotechnology Research
Soteria Bio's top competitors are
Terracoopa,
Sai Nutrition,
Medxcell Sa,
Interchimie,
Ai-Biopharma,
Abiessences,
Laboratoires Rochex,
Microsummits,
Extrasynthese,
Ccrmn Lyon1.
Soteria Bio's categories are Biotechnology Research
